“Pfizer” raises its financial forecast … and 26 billion revenues from the Corona vaccine

0
14


Surpassing expectations and achieving an increase in sales of about 70%.

“Pfizer” company raised expectations about increasing its revenues for this year through a huge launch of the Covid-19 vaccine, in addition to the strong performance achieved by other sectors of the company; As it achieved an increase in sales of about 70%.

The company reported earnings in the first quarter of 2021 of $ 4.88 billion, or 86 cents a share.

Earnings per share came to 93 cents as one-time costs or gains removed, far higher than Wall Street’s forecast of 79 cents; According to a survey conducted by the “Sachs” Foundation for Investment Research.

Revenue was $ 14.58 billion, easily beating industry analysts’ forecasts of $ 13.49 billion; According to what was reported by “The Associated Press”.

And “Pfizer” expects that its profits by the end of this year will range between $ 3.55 to $ 3.65 per share, with revenues ranging from $ 70.5 billion to $ 72.5 billion.

With regard to the revenues that it will achieve from the Corona vaccine, “Pfizer” expects to earn 26 billion dollars this year; This is an increase of 70% from its latest forecast; Due to the increase in vaccination campaigns against the epidemic around the world; According to “Sky News”.

In the first quarter of this year, the Pfizer vaccine achieved revenues of $ 3.5 billion, exceeding expectations of $ 3.28 billion.

Pfizer Inc.
Corona Vaccine

“Pfizer” raises its financial forecast … and 26 billion revenues from the Corona vaccine

Previously

“Pfizer” company raised expectations about increasing its revenues for this year through a huge launch of the Covid-19 vaccine, in addition to the strong performance achieved by other sectors of the company; As it achieved an increase in sales of about 70%.

The company reported earnings in the first quarter of 2021 of $ 4.88 billion, or 86 cents a share.

Earnings per share came to 93 cents as one-time costs or gains removed, far higher than Wall Street’s forecast of 79 cents; According to a survey conducted by the “Sachs” Foundation for Investment Research.

Revenue was $ 14.58 billion, easily beating industry analysts’ forecasts of $ 13.49 billion; According to what was reported by “The Associated Press”.

And “Pfizer” expects that its profits by the end of this year will range between $ 3.55 to $ 3.65 per share, with revenues ranging from $ 70.5 billion to $ 72.5 billion.

With regard to the revenues that it will achieve from the Corona vaccine, “Pfizer” expects to earn 26 billion dollars this year; This is an increase of 70% from its latest forecast; Due to the increase in vaccination campaigns against the epidemic around the world; According to “Sky News”.

In the first quarter of this year, the Pfizer vaccine achieved revenues of $ 3.5 billion, exceeding expectations of $ 3.28 billion.

04 May 2021 – 22 Ramadan 1442

07:13 PM


Surpassing expectations and achieving an increase in sales of about 70%.

“Pfizer” company raised expectations about increasing its revenues for this year through a huge launch of the Covid-19 vaccine, in addition to the strong performance achieved by other sectors of the company; As it achieved an increase in sales of about 70%.

The company reported earnings in the first quarter of 2021 of $ 4.88 billion, or 86 cents a share.

Earnings per share came to 93 cents as one-time costs or gains removed, far higher than Wall Street’s forecast of 79 cents; According to a survey conducted by the “Sachs” Foundation for Investment Research.

Revenue was $ 14.58 billion, easily beating industry analysts’ forecasts of $ 13.49 billion; According to what was reported by “The Associated Press”.

And “Pfizer” expects that its profits by the end of this year will range between $ 3.55 to $ 3.65 per share, with revenues ranging from $ 70.5 billion to $ 72.5 billion.

With regard to the revenues that it will achieve from the Corona vaccine, “Pfizer” expects to earn 26 billion dollars this year; This is an increase of 70% over its latest forecast; Due to the increase in vaccination campaigns against the epidemic around the world; According to “Sky News”.

In the first quarter of this year, the Pfizer vaccine achieved revenues of $ 3.5 billion, exceeding expectations of $ 3.28 billion.





LEAVE A REPLY

Please enter your comment!
Please enter your name here